Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System

Carmine Tomasetti, Chiara Montemitro, Annastasia L. C. Fiengo, Cristina Santone, Laura Orsolini, Alessandro Valchera, Alessandro Carano, Maurizio Pompili, Gianluca Serafini, Giampaolo Perna, Federica Vellante, Giovanni Martinotti, Massimo D. Giannantonio, Yong-Ku Kim, Marco D. Nicola, Antonello Bellomo, Antonio Ventriglio, Michele Fornaro, Domenico D. Berardis*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)381-387
Number of pages7
JournalCurrent Pharmaceutical Design
Volume25
Issue number4
DOIs
Publication statusPublished - 2019

Keywords

  • Depressive disorders
  • glutamate
  • postsynaptic density
  • antipsychotics
  • antidepressants
  • NMDA
  • ketamine
  • mGluR
  • TREATMENT-RESISTANT DEPRESSION
  • TRANSCRANIAL MAGNETIC STIMULATION
  • PREFRONTAL CORTEX
  • ELECTROCONVULSIVE-THERAPY
  • DISORDER
  • SEROTONIN
  • MEMANTINE
  • KETAMINE
  • MODULATION
  • MECHANISMS

Cite this